Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2011-08-09
2011-08-09
Bunner, Bridget E (Department: 1649)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
07994126
ABSTRACT:
Disclosed are compositions comprising Hom polypeptide (also known as Xom, Ventx2) and methods for treating cellular proliferative disorders comprising. Also disclosed are diagnosis methods, prognosis methods, and drug screening methods.
REFERENCES:
patent: 6544962 (2003-04-01), Jones et al.
patent: WO01/75067 (2001-10-01), None
patent: WO2004/076622 (2004-09-01), None
Arseni et al., “The VENT-like homeobox gene ventx2 is expressed in human hematopotetic progenitor cells and promotes human myeloid development in vitro and in vivo.”; Annals of Hematology, (Feb. 2008) vol. 87, No. Suppl. 1, pp. S15.: Conference on Acute Leukemias XII—Biology and Treatment Strategies. Munich, Germany. Feb. 16-20.
Ladher et al. Development, 1996; 122: 2385-2394.
Sadlon et al., 33rd Annual Meeting: ISEH—Abstracts/Experimental Hematology 2004; 32: 31-104, Abstract #30.
Gao et al., Gastroenterology, (Apr. 2005) vol. 128, No. 4, Suppl. 2, p. A488. Annual Meeting of the American-Gastroenterological-Association/Digestive-Disease-Week. Chicago, IL, USA. May 14-19, 2005. Amer Gastroenterol Assoc.; abstract T1482.
Gao et al. Gastroenterology, (Apr. 2008) vol. 134, No. 4, Suppl. 1, p. Digestive Disease Week Meeting/109th Annual Meeting of the American-Gastroenterological-Association. San Diego, CA, USA. May 17 -22, 2008. Amer Gastroenterol Assoc.; abstract W1966.
Tannock and Hill. The Basic Science of Oncology. 1998. New York: McGraw-Hill.
Song et al., Expert Opin Biol Ther 7(4): 431-438, 2007.
van der Wouden et al., Cochrane Database Syst Rev. 2009; 7: CD004767.
Gorouhi and Maibach, International Journal of Cosmetic Science; 2009: 31: 327-345.
Kligman et al., Dermatol Surg. 1998; 24:325-8.
Rocklin et al., J. Immunol. 1981; 127: 534-539.
Lee et al., JBC, 1996; 271: 11897-11903.
Griffiths et al., N Engl J Med. 1993; 329: 530-5.
International Search Report and Written Opinion issued for International Application No. PCT/US07/62587, dated Sep. 5, 2008, 14 pages.
Moretti et al., “Molecular Cloning of a Human Vent-Like Homeobox Gene,”Genomics, vol. 76, No. 1-3, pp. 21-29, (2001).
Reya et al., “Wnt signaling in stem cells and cancer,”Nature, vol. 434, pp. 843-850, (2005).
XP002557883 Arseni et al.; “The vent-like homeobox gene VENTX2 is a novel candidate for a human hematopoietic regulatory protein” Annals of Hematology; vol. 85, No. Suppl 1., Feb. 2006 p. 18.
XP002557884 Database EMBL Sequence 401 from Patent W020044076622, Sep. 27, 2004.
XP002557886 Moreau-Aubry et al; A processed pseudogene codes for a new antigen recognized by a CD8<+> T cell clone on melanoma; Journal of Experimental Medicine; 191(9):1617-1623, May 1, 2000.
XP002557887 Grier et al.; The pathophysiology of HOX genes and their role in cancer; Journal of Pathology; 205(2):154-171 Jan. 2, 2005.
XP002557888 Database Geneseq Feb. 18, 2002.
XP002557889 Database Biosis “regulation of Bmp4 signaling by phosphorylation dependent proteolysis of xom”; Apr. 2005.
XP002557890 Hong et al.; “Hom-1 inhibits tumor growth in both p53 sufficient and deficient colon cancer cells”; Gastroenterology, 134(4), Suppl. 1 p. A744 Apr. 2008.
XP002557891 Arseni et al; “The vent-like homeobox gene VENTX2 is expressed in human hematopoietic progenitor cells and promotes human myeloid development in vitro and in vivo” Blood; 110(11) part 1; pp. 383A-384A, 2007.
XP002557892 Arseni et al.; “VENTX2-A vent-like homeobox gene- is a novel candidate for a hematopoietic regulatory protein”; Experimental Hematology; 35(9), Suppl. 2 p. 45, Sep. 2007.
XP002557894 Hong et al.; “Xom interacts with and stimulates transcriptional activity of LEF1/TCFs: implications for ventral cell fate determination during vertebrate embryogenesis” Cell Research; 17(4):345-356, Apr. 2007.
Gao Hong
Zhu Zhenglun
Borgeest Christina
Bunner Bridget E
Gao Hong
Occhiuti Rohlicek & Tsao LLP
Zhu Zhenglun
LandOfFree
Treatment of cellular proliferative disorders with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of cellular proliferative disorders with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of cellular proliferative disorders with... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2627152